FIPB sends Glenmark, Aurobindo FDI proposals to CCEA, clears 11
20 Feb 2015 11:53 PM GMT
FIPB has cleared foreign investment in 11 entities, entailing Rs 1,075.91 crore, and referred proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.
“Based on the recommendation of Foreign Investment Promotion Board (FIPB) in its meeting held on February 4, 2015, the government has approved 11 proposals of Foreign Direct Investment (FDI) amounting to Rs 1,075.91 crore approximately,” the Finance Ministry said in a statement.
FIPB cleared the proposal of Mumbai-based SeQuent Scientific Ltd for raising Rs 400 crore through QIP and issue of Foreign Currency Convertible Bonds. JP Morgan Asset Management (Asia) Inc USA has got approval for the acquisition of remaining 25 per cent held by JP Morgan India Pvt Ltd in the joint venture set up in 2006 by the two companies. It entails investment up to Rs 80.13 crore. The proposal of BLP Wind Assets Holding Pvt Ltd for setting up a joint venture firm for making downstream investments in the renewable energy sector has been approved. It entails an investment of Rs 371 crore.
However, FIPB has sent the proposal of Mumbai-based Glenmark Pharmaceuticals to the Cabinet Committee on Economic Affairs, headed by Prime Minister Narendra Modi, to raise the cap of foreign institutional investor (FII) holding to 49 per cent, from 35.07 per cent at present. FIBP has also sent the proposal of Hyderabad-based Aurobindo Pharma for bringing in Rs 2,165 crore foreign investment by Qualified Institutional Buyers to the CCEA. “The two proposals have been recommended for consideration of the CCEA, as the investment involved in each of the proposal is above Rs 1,200 crore,” the statement said.
Besides, FIPB has deferred an investment proposal of Hyderabad- based Mylan Laboratories Limited for increase in the level of FDI in company by existing non-resident shareholders, MP Laboratories (Mauritius) Ltd, and Mylan Luxembourg 2, pursuant to a composite scheme of arrangements. It rejected foreign investment application of Johnson and Johnson Limited’s proposal seeking deletion of the standard pharma conditions, stipulated in the approved letter.
The other proposals cleared by FIPB include Solar Arise India Pvt Ltd for receiving FDI from overseas investors and investing in various SPVs for solar projects.
“Based on the recommendation of Foreign Investment Promotion Board (FIPB) in its meeting held on February 4, 2015, the government has approved 11 proposals of Foreign Direct Investment (FDI) amounting to Rs 1,075.91 crore approximately,” the Finance Ministry said in a statement.
FIPB cleared the proposal of Mumbai-based SeQuent Scientific Ltd for raising Rs 400 crore through QIP and issue of Foreign Currency Convertible Bonds. JP Morgan Asset Management (Asia) Inc USA has got approval for the acquisition of remaining 25 per cent held by JP Morgan India Pvt Ltd in the joint venture set up in 2006 by the two companies. It entails investment up to Rs 80.13 crore. The proposal of BLP Wind Assets Holding Pvt Ltd for setting up a joint venture firm for making downstream investments in the renewable energy sector has been approved. It entails an investment of Rs 371 crore.
However, FIPB has sent the proposal of Mumbai-based Glenmark Pharmaceuticals to the Cabinet Committee on Economic Affairs, headed by Prime Minister Narendra Modi, to raise the cap of foreign institutional investor (FII) holding to 49 per cent, from 35.07 per cent at present. FIBP has also sent the proposal of Hyderabad-based Aurobindo Pharma for bringing in Rs 2,165 crore foreign investment by Qualified Institutional Buyers to the CCEA. “The two proposals have been recommended for consideration of the CCEA, as the investment involved in each of the proposal is above Rs 1,200 crore,” the statement said.
Besides, FIPB has deferred an investment proposal of Hyderabad- based Mylan Laboratories Limited for increase in the level of FDI in company by existing non-resident shareholders, MP Laboratories (Mauritius) Ltd, and Mylan Luxembourg 2, pursuant to a composite scheme of arrangements. It rejected foreign investment application of Johnson and Johnson Limited’s proposal seeking deletion of the standard pharma conditions, stipulated in the approved letter.
The other proposals cleared by FIPB include Solar Arise India Pvt Ltd for receiving FDI from overseas investors and investing in various SPVs for solar projects.
Next Story
